These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1421 related articles for article (PubMed ID: 24857062)
21. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy. Farwell MD; Clark AS; Mankoff DA JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243 [No Abstract] [Full Text] [Related]
22. NCI-MATCH launch highlights new trial design in precision-medicine era. McNeil C J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446 [No Abstract] [Full Text] [Related]
23. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?]. Albin N; Mc Leer A; Sakhri L Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomic biomarkers for personalized cancer treatment. RodrÃguez-Antona C; Taron M J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550 [TBL] [Abstract][Full Text] [Related]
25. Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision Medicine. Tsimberidou AM; Said R; Staudt LM; Conley BA; Takebe N Cancer J; 2019; 25(4):296-299. PubMed ID: 31335394 [TBL] [Abstract][Full Text] [Related]
26. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia. Molloy MP; Engel A Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786 [No Abstract] [Full Text] [Related]
27. Precision oncology: A new era of cancer clinical trials. Renfro LA; An MW; Mandrekar SJ Cancer Lett; 2017 Feb; 387():121-126. PubMed ID: 26987624 [TBL] [Abstract][Full Text] [Related]
28. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment. Schmidt KT; Chau CH; Price DK; Figg WD J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880 [TBL] [Abstract][Full Text] [Related]
30. Precision and predictive medicine in urothelial cancer: are we making progress? Bellmunt J; Orsola A; Sonpavde G Eur Urol; 2015 Oct; 68(4):547-9. PubMed ID: 25935702 [TBL] [Abstract][Full Text] [Related]
31. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer. Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271 [TBL] [Abstract][Full Text] [Related]
32. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience. Lih CJ; Takebe N Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332 [TBL] [Abstract][Full Text] [Related]
33. Pediatric oncology enters an era of precision medicine. Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740 [TBL] [Abstract][Full Text] [Related]
34. Precision medicine in pediatric oncology. Forrest SJ; Geoerger B; Janeway KA Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430 [TBL] [Abstract][Full Text] [Related]
35. Next steps in clinical trial redesign. Nicholas J J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851 [No Abstract] [Full Text] [Related]
36. Anticipating designer drug-resistant cancer cells. Frangione ML; Lockhart JH; Morton DT; Pava LM; Blanck G Drug Discov Today; 2015 Jul; 20(7):790-3. PubMed ID: 25697478 [TBL] [Abstract][Full Text] [Related]
37. The Future of Precision Oncology for the Treatment of Solid Tumors. Klute KA Clin Pharmacol Ther; 2020 Sep; 108(3):416-418. PubMed ID: 31983061 [No Abstract] [Full Text] [Related]
38. New tools for old drugs: Functional genetic screens to optimize current chemotherapy. Gerhards NM; Rottenberg S Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836 [TBL] [Abstract][Full Text] [Related]
39. Definitions and statistical properties of master protocols for personalized medicine in oncology. Renfro LA; Mandrekar SJ J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine. Eke I; Makinde AY; Aryankalayil MJ; Ahmed MM; Coleman CN Cancer Lett; 2016 Nov; 382(1):118-126. PubMed ID: 26828133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]